Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials.
about
Albumin and other plasma expanders for paracentesis treatment of ascites in cirrhotic patientsPro/con clinical debate: do colloids have advantages over crystalloids in paediatric sepsis?Paper reports overview: Cranberry juice, fluid replacement and bad innovationsPharmaceutical-grade albumin: impaired drug-binding capacity in vitro22nd International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 19-22 March 2002Albumin in critical care: SAFE, but worth its salt?Q24801818Recently published papers: what not to do and how not to do it?Fluid Management for Critically Ill Patients: A Review of the Current State of Fluid Therapy in the Intensive Care UnitAlbumin administration in the acutely ill: what is new and where next?Albumin for end-stage liver diseaseReview of the rational use and adverse reactions to human serum albumin in the People's Republic of ChinaIs albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study.Choice of fluids for resuscitation in children with severe infection and shock: systematic reviewPart 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.Does serum albumin and creatinine predict survival of inpatient palliative care patients?Commentary: Saline versus Albumin Fluid Evaluation (SAFE) Investigators (2006). Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline vPerioperative Care of Patients With Liver Cirrhosis: A Review.The effect of excess fluid balance on the mortality rate of surgical patients: a multicenter prospective study.Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke.Drug insight: the role of albumin in the management of chronic liver disease.Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis.Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials.The immunomodulatory effects of albumin in vitro and in vivo.Review article: volume expansion in patients with cirrhosis.Management of septic shock.Parachute approach to evidence based medicine.How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure.Fluid choice for resuscitation of the trauma patient: a review of the physiological, pharmacological, and clinical evidence.Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review.Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement.Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.Efficacy of limited fluid resuscitation in patients with hemorrhagic shock: a meta-analysisDeath, morbidity and economics are the only end points for trials.Albumin therapy in clinical practice.Comparative quantitative acid-base analysis in coronary artery bypass, severe sepsis, and diabetic ketoacidosis.Hypoalbuminemia in renal failure: pathogenesis and therapeutic considerations.Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT.Treatment options for severe sepsis and septic shock.Considerations in fluids and electrolytes after traumatic brain injury.
P2860
Q24250552-E68E2EBA-F14C-436E-B227-D31D3C97C67AQ24796807-14E1D6F0-7BCC-4E60-AC30-62510044DD17Q24797886-072AD1C2-7098-4097-9173-74C486EB934AQ24798284-6292C19C-5BCA-424C-814E-FFDC4275B6F8Q24798640-7E9F5F1A-4F3B-4FBB-8E73-89FC7DD4BCA6Q24800354-7DC16724-2BEE-409A-8127-9CB84D78167CQ24801818-052DFEE9-03CE-4333-8CB6-9E9912E57178Q24813548-8E1FC707-DB00-4D7C-91D2-905F950BDD89Q26740419-7C428385-CB90-4F13-9ACF-100A1796D9DBQ26853626-E8B2C4AB-E2BF-4861-85FB-CD0373EB5A0DQ26999804-45B33680-84C4-4449-A030-C78C032E3074Q27001514-D053FE8C-F6AD-42A3-BB2F-16E7F0C5EB75Q28193956-D41EEDD6-13A6-458A-AA9B-C848E0662B65Q28749460-A3698DDE-A2AF-4E1A-900C-09412C27FA72Q30543305-FF8B75F8-48ED-450B-A8FA-7BA13605FF8AQ31128680-B8C72E97-234D-403D-88AF-4A4DF6F1153CQ31130238-BC054056-5907-42FB-A63A-D42855FB3C23Q33441586-FD485543-0622-43B3-9788-D22215C94FFEQ33753603-3B892757-BC7E-49F0-8F19-5A8ABC5FF837Q33882182-8A601D66-BAD7-4053-AE06-23A72CC8B18AQ34597754-4409580D-1DB6-4821-B086-5E4D9B6275A1Q34636813-16448DC6-22B2-476F-8B0A-8C25E0880ECAQ34837478-838053D0-4C5F-42EB-A427-194A653FD69EQ34986066-53D73580-8D80-483B-A018-981E5FEADB75Q34992529-B546D04C-468A-4E76-8F59-973E2AB77D10Q35055021-E692285D-31FD-419C-86B2-B8F9CE623168Q35060383-46CA75E7-9019-4EFF-AD4B-902CABF6C404Q35185107-F3470D79-D066-4CB8-AEDB-ABE9EDCA05D7Q35765217-FF2D5A4B-7360-4793-85D6-C4483DD0B7ECQ35895145-E277497D-07D7-47A3-9E23-1098FFC38E1FQ35962710-2C3A87B3-D4F7-4B12-9C31-9B8C91B25BA0Q36003964-11830D4C-B8D1-4862-A518-8E7177A791A1Q36046918-B9602524-D5D4-44C2-AC16-646D96156D20Q36209800-E81081F0-50FC-4502-B6BF-D9E417157681Q36278377-7B3590C5-229C-4F76-8D4B-E66940785FCCQ36310355-54CE060C-10BF-4ADD-9AAC-764FFBEA9806Q36420231-1A7456C7-5464-4350-BA13-AF4AF367A4A8Q36468598-569D022D-310B-4EAA-9C06-EADADF9606D4Q36505487-51A87226-6923-4F0A-82F5-1D561EC564D3Q36602392-B4B5C26E-14A4-4A41-9CF4-552F6134F876
P2860
Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Patient survival after human a ...... randomized, controlled trials.
@ast
Patient survival after human a ...... randomized, controlled trials.
@en
type
label
Patient survival after human a ...... randomized, controlled trials.
@ast
Patient survival after human a ...... randomized, controlled trials.
@en
prefLabel
Patient survival after human a ...... randomized, controlled trials.
@ast
Patient survival after human a ...... randomized, controlled trials.
@en
P1476
Patient survival after human a ...... randomized, controlled trials.
@en
P2093
Navickis RJ
P304
P356
10.7326/0003-4819-135-3-200108070-00007
P407
P577
2001-08-01T00:00:00Z